For: | Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: A meta-analysis. World J Gastroenterol 2011; 17(9): 1227-1233 [PMID: 21448430 DOI: 10.3748/wjg.v17.i9.1227] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i9/1227.htm |
Number | Citing Articles |
1 |
Jinghui Li, Xiaoyu Liu, Yu Qiao, Renli Qi, Shunjin Liu, Jing Guo, Yang Gui, Juanjuan Li, Hualin Yu. Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00413
|
2 |
Haibo Zhang, Shanhu Hao, Junhua Zhao, Baosen Zhou, Yangwu Ren, Ying Yan, Yuxia Zhao. Common Genetic Variants in 53BP1 Associated with Nonsmall-cell Lung Cancer Risk in Han Chinese. Archives of Medical Research 2014; 45(1): 84 doi: 10.1016/j.arcmed.2013.10.011
|
3 |
Marilanda Ferreira Bellini, Aline Cristina Targa Cadamuro, Maysa Succi, Marcela Alcântara Proença, Ana Elizabete Silva. Alterations of theTP53Gene in Gastric and Esophageal Carcinogenesis. Journal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/891961
|
4 |
Daniel J Renouf, Rihong Zhai, Bin Sun, Wei Xu, Winson Y Cheung, Rebecca S Heist, Matthew H Kulke, David Cescon, Kofi Asomaning, Ariella L Marshall, Su Li, David C Christiani, Geoffrey Liu. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology 2013; 28(9): 1482 doi: 10.1111/jgh.12286
|
5 |
Sukhpreet Kaur, Vasudha Sambyal, Kamlesh Guleria, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh, Gursimran Singh, Harpreet Singh. Analysis of TP53 Polymorphisms in North Indian Sporadic Esophageal Cancer Patients. Asian Pacific Journal of Cancer Prevention 2014; 15(19): 8413 doi: 10.7314/APJCP.2014.15.19.8413
|
6 |
Jayanta Sarkar, Emily Dominguez, Guojun Li, Donna F. Kusewitt, David G. Johnson. Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility. Molecular Carcinogenesis 2014; 53(8): 648 doi: 10.1002/mc.22019
|
7 |
Wanli Yang, Yu Han, Xinhui Zhao, Lili Duan, Wei Zhou, Xiaoqian Wang, Gaokai Shi, Yinggang Che, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 2019; 19(2): 109 doi: 10.1080/14737159.2019.1563485
|
8 |
Helena S Thurow, Ricardo Haack, Fernando P Hartwig, Isabel O de Oliveira, Odir A Dellagostin, Denise P Gigante, Bernardo L Horta, Tiago Collares, Fabiana K Seixas. TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. Journal of Biosciences 2011; 36(5): 823 doi: 10.1007/s12038-011-9147-5
|
9 |
O. Bulgakova, A. Kussainova, R. Bersimbaev. The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis. Vavilov Journal of Genetics and Breeding 2020; 24(7): 77 doi: 10.18699/VJ20.673
|
10 |
Hamida Ali, Muhammad Naeem, Naheed Sajjad, Gul Naz, Abdul Samad, Hafiz Khush Naseeb, Nabeela Tariq. PCR-RFLP genotyping analysis of TP53 Arg72Pro polymorphism and susceptibility to esophageal cancer in Pakistani population. Gene Reports 2021; 25: 101406 doi: 10.1016/j.genrep.2021.101406
|
11 |
Süleyman Bayram, Eyyüp Rencüzoğulları, Abdullah Muttalip Almas, Ahmet Genç. Effect of p53 Arg72Pro polymorphism on the induction of micronucleus by aflatoxin B1 in in vitro in human blood lymphocytes. Drug and Chemical Toxicology 2016; 39(3): 331 doi: 10.3109/01480545.2015.1121275
|
12 |
Su-Qin Shen, De-Ke Jiang, Guo-Yuan Liu, Fang Chen, Long Yu. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk. Molecular Biology Reports 2012; 39(4): 4683 doi: 10.1007/s11033-011-1260-x
|
13 |
Wenlei Zhuo, Liang Zhang, Yan Wang, Bo Zhu, Zhengtang Chen. Cyclin D1 G870A Polymorphism is a Risk Factor for Esophageal Cancer Among Asians. Cancer Investigation 2012; 30(9): 630 doi: 10.3109/07357907.2012.726385
|
14 |
D. E. Ivanoshchuk, S. V. Mikhailova, I. V. Kulikov, V. N. Maksimov, M. I. Voevoda, A. G. Romashchenko. CCR5, CCR2, apoE, p53, ITGB3, and HFE gene polymorphism in Western Siberian long livers. Advances in Gerontology 2013; 3(2): 89 doi: 10.1134/S2079057013020082
|
15 |
Juan Cao, Zhiqiang Chen, Chaoyong Tian, Jia Yu, Hongfei Zhang, Jingwen Yang, Wenjun Yang. A Shared Susceptibility Locus in the p53 Gene for both Gastric and Esophageal Cancers in a Northwestern Chinese Population. Genetic Testing and Molecular Biomarkers 2020; 24(12): 804 doi: 10.1089/gtmb.2020.0192
|
16 |
M. Brunotto, A.M. Zarate, A. Bono, J.L. Barra, S. Berra. Risk genes in head and neck cancer: A systematic review and meta-analysis of last 5years. Oral Oncology 2014; 50(3): 178 doi: 10.1016/j.oraloncology.2013.12.007
|
17 |
Huda A. Eltahir, Ameera A. M. Adam, Zeinab A. Yahia, Noon F. Ali, Dalia M. Mursi, Ashraaf M. Higazi, Nahid A. Eid, Ahmed M. Elhassan, Hiba S. Mohammed, Muntaser E. Ibrahim. p53 Codon 72 arginine/proline polymorphism and cancer in Sudan. Molecular Biology Reports 2012; 39(12): 10833 doi: 10.1007/s11033-012-1978-0
|